Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Sales | 11 | 0 | 0 | 0 | 0 |
| Cost of Goods | 14 | N/A | N/A | N/A | N/A |
| Gross Profit | -3 | N/A | N/A | N/A | N/A |
| Operating Expenses | 1,302 | 544 | 818 | 451 | 359 |
| Operating Income | -1,305 | -544 | -818 | -451 | -359 |
| Other Income | 0 | 0 | 0 | -8 | 0 |
| Pre-tax Income | -1,305 | -544 | -818 | -459 | -359 |
| Net Income Continuous | -1,305 | -544 | -818 | -459 | -359 |
| Net Income | $-1,305 | $-544 | $-818 | $-459 | $-359 |
| EPS Basic Total Ops | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-1,305 | $-544 | $-817 | $-458 | $-359 |